After more than four years of intensive research, SciLifeLab Group leader, Sara Mangsbo (Uppsala University), and her immunotherapeutic cancer vaccine delivery-platform, is ready to leave the SciLifeLab Drug Discovery and … Continue reading Latest DDD-platform exit: Immunotherapeutic cancer vaccine delivery-platform